Immune thrombocytopenia (ITP) is an autoimmune disorder characterised by both antibody-mediated platelet destruction and impaired megakaryocyte function. This results in decreased platelet counts and ...
“Doptelet represents a significant advancement in the treatment of children and adolescents with persistent or chronic ITP,” said Rachael Grace, MD, MMSc, Pediatric Hematologist and Director, ...
The addition of ianalumab to eltrombopag significantly prolonged the duration of safe platelet levels. Ianalumab added to eltrombopag significantly prolonged the time to treatment failure (TTF) in ...
An expert discusses how ITP treatment success is monitored through maintaining safe platelet levels and symptom control, managing relapses, and tailoring follow-up based on therapy type and patient ...
Takeda (TSE:4502/NYSE:TAK) today announced new interim data from the Phase 1b, open-label, proof-of-concept study of ...
25d
Sanofi: Sanofi's Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia
Sanofi's Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia Recommendation based on LUNA 3 phase 3 study demonstrating rapid and durable platelet response and significant ...
If you have immune thrombocytopenia (ITP) and are struggling with fatigue, you’re not alone. In an international survey of 1,507 people with ITP, as many as 73 percent reported fatigue as their most ...
If you’re struggling with anxiety, depression, or stress, which are common in people with this condition, these tips can help. Living with immune thrombocytopenia (ITP) can carry a certain amount of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback